| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 02/06/2003 | WO2001070765A9 Receptor-binding compounds and methods for identifying them |
| 02/06/2003 | US20030027987 Novel polypeptide from Haemophilus paragallinarum and process for preparing the same |
| 02/06/2003 | US20030027980 Process for preparing lipid ii |
| 02/06/2003 | US20030027819 Administering to an animal in need for protease inhibition an effective amount of substituted heterobicyclic compound containing amino acid side chains |
| 02/06/2003 | US20030027767 To cause apoptosis in colon cancer and prostate cancer cells |
| 02/06/2003 | US20030027246 Prostate protein for use in the diagnosis and treatment of cancer |
| 02/06/2003 | US20030026800 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 02/06/2003 | CA2455602A1 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 02/06/2003 | CA2454784A1 Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques |
| 02/05/2003 | EP1281702A2 Calcium receptor active molecules |
| 02/05/2003 | EP1281405A2 Short-chained peptide-dye conjugates as contrast agents for optical diagnosis |
| 02/05/2003 | EP1280820A2 Anti-inflammatory compounds and uses thereof |
| 02/05/2003 | CN1394871A Staphylococcus aureus virulence stimulating factor inhibiting peptide and its application |
| 02/04/2003 | US6515103 Polypeptides naturally occurring in venom of cone snails; include gamma-carboxyglutamic acid; use as anticonvulsant, neuroprotective, and pain management agents |
| 02/04/2003 | US6514759 Isolating a conditioned medium containing a peptide of given formula from a liliaceous plant; use in promoting cell growth of asparagus, rice and maize |
| 02/04/2003 | US6514727 Isolated nucleic acid molecule encoding a cyclic peptide having amino acids linked by peptide bonds and interchain crosslinks. |
| 02/04/2003 | US6514710 Method of using cyclic peptides to inhibit binding to urokinase-type plasminogen activator receptor |
| 02/04/2003 | US6514691 An antigenic envelope polypeptide of given amino acid sequence was identified |
| 02/04/2003 | CA2171953C Modified truncated complement system regulators |
| 01/30/2003 | WO2003008578A2 Reagents and methods for identifying gene targets for treating cancer |
| 01/30/2003 | WO2003008537A2 Epitope sequences |
| 01/30/2003 | WO2003008444A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003008443A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003008431A1 Process for producing sugar chain asparagine derivative |
| 01/30/2003 | WO2003007978A1 Alpha-fetoprotein peptides and uses thereof |
| 01/30/2003 | WO2003007689A2 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 01/30/2003 | WO2003007686A2 Use of copper chelators to inhibit the inactivation of protein c |
| 01/30/2003 | WO2002068585A9 Tip39 polypeptides |
| 01/30/2003 | WO2002066500A3 ANTAGONISTS FPR Α4β7-INTEGRIN |
| 01/30/2003 | WO2002064160A8 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 01/30/2003 | WO2002048180A3 Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament |
| 01/30/2003 | WO2002045523A3 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 01/30/2003 | WO2002007773A3 Multi-component biological transport systems |
| 01/30/2003 | WO2001079286A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 01/30/2003 | US20030023104 For prolonging or altering the activity of a compound which is a member of the chlorambucil family |
| 01/30/2003 | US20030023047 For prevention of influenza virus binding to cells, therapy of schizophrenia and diagnosing chronic viral disease associated with development of cancer |
| 01/30/2003 | US20030022831 Compositions employ a delivery enhancing transporter that has sufficient guanidino or amidino sidechain moieties to enhance delivery of compound conjugated to reagent across one or more layers of tissue, compared to non-conjugated compound |
| 01/30/2003 | US20030022236 Generation of preferental protein libraries; obtain nucleotide sequences, translate in vitro, recover protein product |
| 01/30/2003 | US20030022158 Peptide for use in the treatment of viral infection |
| 01/30/2003 | US20030021795 Administering antibody; determination binding to peptide |
| 01/30/2003 | US20030021794 Heat shock protein-based vaccines and immunotherapies |
| 01/30/2003 | CA2454423A1 Method and reagents for identifying gene targets for treating breast cancer |
| 01/30/2003 | CA2454418A1 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 01/30/2003 | CA2453967A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | CA2453965A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/29/2003 | EP1279678A1 Gag antigen and other orf fragments of lav virus. Use for the detection of lav infection and in immunogenic compositions |
| 01/29/2003 | EP1278849A2 Thrombopoietin receptor modulating peptide |
| 01/29/2003 | EP1278765A2 Immunodominant acetylcholine receptor alpha subunit peptides, complexes thereof with mhc class ii components and their use |
| 01/29/2003 | EP1278534A1 Methods and compositions for impairing multiplication of hiv-1 |
| 01/29/2003 | EP0753005B1 Cytotoxic t-cell lymphocyte ("ctl") activity regulation by class i mhc peptides |
| 01/29/2003 | CN1393474A Affinity peptide of tumor necrosis factor receptor and its application |
| 01/29/2003 | CN1099893C Sustained-release preparation |
| 01/28/2003 | US6512092 Solid phase peptide synthesis; in situ generation of amino acid chloride by deblocking; coupling sterically hindered amino acid residues |
| 01/28/2003 | US6511962 Intermediates useful for synthesizing laspartomycin derivatives as well as the laspartomycin derivatives |
| 01/28/2003 | US6511961 Treating allergic inflammatory disease or hepatitis comprising administering to a subject an effective amount of a cyclic peptide having VLA-4 (very late antigen-4) adhesion activity |
| 01/28/2003 | US6511811 Protein kinase C antagonist related to insulin receptor |
| 01/28/2003 | CA2258906C Amides |
| 01/28/2003 | CA2222698C Use of bradykinin antagonists for stimulating or inducing hair growth and/or arresting hair loss |
| 01/28/2003 | CA2127553C Peptides with organo-protective activity, process for their preparation and their use in the therapy |
| 01/23/2003 | WO2003006620A2 Linear and cyclic melanocortin receptor-specific peptides |
| 01/23/2003 | WO2003006604A2 Cyclic peptides as potent and selective melanocortin-4 receptor agonists |
| 01/23/2003 | WO2003006494A1 Peptide beta-barrels |
| 01/23/2003 | WO2003006492A2 Biologically active peptides |
| 01/23/2003 | WO2003006491A2 Peptide-based compounds for targeting intergin receptors |
| 01/23/2003 | WO2003006490A1 Bridged bicyclic serine protease inhibitors |
| 01/23/2003 | WO2003006070A2 Improved chelator conjugates |
| 01/23/2003 | WO2003006049A1 Gonadotropin releasing hormone antagonists in gel-forming concentrations |
| 01/23/2003 | WO2003006047A2 Methods for reducing immunogenicity of polypeptides |
| 01/23/2003 | WO2003006043A1 Surfactant peptide nanostructures, and uses thereof |
| 01/23/2003 | WO2003006042A1 Peptide for regulation of tissue plasminogen activator |
| 01/23/2003 | WO2003005956A2 A hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity |
| 01/23/2003 | WO2002038592A3 Peptides, the production and use thereof for binding immunoglobulins |
| 01/23/2003 | WO2002012272A3 Therapeutic anti-melanoma compounds |
| 01/23/2003 | US20030018438 Binding compounds and methods for identifying binding compounds |
| 01/23/2003 | US20030018184 Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor |
| 01/23/2003 | US20030018164 Automatic biosynthesis cycles |
| 01/23/2003 | US20030017991 Substrates and assays for beta-secretase activity |
| 01/23/2003 | US20030017990 Antiinflammatory agents, rheumatic diseases, antiarthritic agents, inflammatory bowel disorders |
| 01/23/2003 | US20030017988 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis |
| 01/23/2003 | US20030017970 Wound healing compositions |
| 01/23/2003 | US20030017170 Methods for inhibiting tumor metastasis, and peptides useful therefor |
| 01/23/2003 | US20030017156 Immunogenic polypeptide |
| 01/23/2003 | CA2707767A1 Biologically active peptides |
| 01/23/2003 | CA2453515A1 Linear and cyclic melanocortin receptor-specific peptides |
| 01/23/2003 | CA2453406A1 Methods for reducing immunogenicity of polypeptides |
| 01/23/2003 | CA2453346A1 A hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity |
| 01/23/2003 | CA2453309A1 Peptide for regulation of tissue plasminogen activator |
| 01/23/2003 | CA2453027A1 Cyclic peptides as potent and selective melanocortin-4 receptor agonists |
| 01/23/2003 | CA2452417A1 Compositions comprising the biologicially active peptide ysl |
| 01/23/2003 | CA2449504A1 Bridged bicyclic serine protease inhibitors |
| 01/22/2003 | EP1276758A2 A glycopeptide and preparation thereof |
| 01/22/2003 | EP1276746A2 Process for preparing lipid ii and derivatives thereof |
| 01/22/2003 | EP1276491A1 Tamandarin and didemnin analogs and methods of making and using them |
| 01/22/2003 | CN1392798A Mimetic peptides for epitope of apolipoprotein B-100, concatemer and modified peptides, and vaccine composition comprising same |
| 01/22/2003 | CN1392158A Pentadeca-peptide capable of specifically binding with intercellular adhesion molecule-1 |
| 01/21/2003 | US6509450 Immunoassay for quantification of C-terminal telopeptides of type I collagen in human serum |
| 01/21/2003 | US6509446 Recombinant genetic information (DNA or RNA), consisting a Chicken Anemia Virus (CAV)-specific nucleotide sequence, useful for diagonestics, vaccination or protein production |
| 01/21/2003 | US6509315 Didemnin analogs and fragments and methods of making and using them |
| 01/21/2003 | US6509165 Detecting the ability of proinsulin peptide to preferentially stimulate the T-cells of diabetic subjects by measuring the ability of the T-cells to proliferate or ability of the T-cells to produce cytokines |
| 01/16/2003 | WO2003004646A2 Genetic analysis of peyers's patches and m cells and methods and compositions targeting peyer's patches and m cell receptors |